Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and Topotecan with Filgrastim-SD/01 in Aggressive NHL
NCT00038545Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 2001
- Primary completion
- Apr 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel and topotecan in non-Hodgkin lymphoma (NHL), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Overall Response Rate. Started May 2001; status: completed.
02
Drugs
paclitaxeltopotecan
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00038545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038545.